Category Collection

Popular

Ddm3pcms Sam Billings 625x300 16 April 25
On IPL vs PSL Debate, Ex-CSK Star Sam Billings’ Cheeky “Want Me To Say Something Silly” Take
IPL 2025 Points Table, Orange Cap, Purple Cap: Delhi Capitals Reclaim Top Spot After Super Over Drama vs Rajasthan Royals
Sanju Samson Forced To Retire Hurt Against Delhi Capitals. Commentator Says ‘Tear In…’
Karun Nair Fumes In Dressing Room After Three-Ball Duck Against Rajasthan Royals – Reaction Is Viral

Trending News

Ddm3pcms Sam Billings 625x300 16 April 25
On IPL vs PSL Debate, Ex-CSK Star Sam Billings’ Cheeky “Want Me To Say Something Silly” Take 01
02
IPL 2025 Points Table, Orange Cap, Purple Cap: Delhi Capitals Reclaim Top Spot After Super Over Drama vs Rajasthan Royals
03
Sanju Samson Forced To Retire Hurt Against Delhi Capitals. Commentator Says ‘Tear In…’
04
Karun Nair Fumes In Dressing Room After Three-Ball Duck Against Rajasthan Royals – Reaction Is Viral
05
Holger Rune, Arthur Fils Reach Barcelona Open Quarter-Finals
06
Andre Onana To Return In Goal For Manchester United Against Lyon: Ruben Amorim
Zlataky Cz 44ewivJ9t1k Unsplash 1646898717970 1701067646117 1744871288657

Gold prices hit fresh high! Key factors behind the rally; technicals suggest resistance at THIS level

Gold prices in India and globally surged to fresh lifetime highs on Thursday, April 17, as renewed geopolitical tensions, fears of stagflation, and a weakening US dollar spurred strong safe-haven buying. Amid escalating trade conflicts between the United States and China, investors rushed toward gold to shield themselves from growing macroeconomic uncertainty. The spike also…

Read More
Cipla S GAdvair And GAbraxane Products Are Awaitin 1684146419132 1744870962995

Does US approval for key cancer drug make Cipla shares an attractive buy amid tariff concerns?

Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump’s tariffs are looming on the horizon? “One product approval by itself doesn’t suddenly make a company more attractive,” said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. “Earlier-than-expected approval for Abraxane is positive,…

Read More
Enable Notifications OK No thanks